Altre lingue NeuroPace, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 19:00:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
7,24 ^USD	+0,14%		+5,69%	-29,78%

13/05	NEUROPACE, INC. : Morgan Stanley ribadisce il giudizio Neutral	ZM
08/05	NeuroPace, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2500 Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000E Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000 Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2000 Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2000 Dynamic Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell Small Cap Comp Growth Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 2500 Index	01/07
NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell 3000 Index	01/07
NeuroPace to Participate in Two Healthcare Conferences in May	14/05
NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Earnings Flash (NPCE) NEUROPACE Posts Q1 Revenue $18.1M, vs. Street Est of $17.3M	08/05
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update	08/05
NeuroPace, Inc. Reaffirms Earnings Guidance for the Year 2024	08/05
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024	17/04
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference	27/03
North American Morning Briefing : Inflation -2-	15/03
NeuroPace Shares Decline Following Q4 Financial Results	06/03
NeuroPace, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
NeuroPace, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Earnings Flash (NPCE) NEUROPACE Reports Q4 Revenue $18M, vs. Street Est of $17.7M	05/03

Non ci sono risultati per questa ricerca